Key Details
Price
$1.44Annual ROE
-31.90%Beta
0.60Events Calendar
Next earnings date:
Mar 05, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Apr 07, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 09, 2022Analyst ratings
Recent major analysts updates
17 Aug '23 Cantor Fitzgerald
Neutral13 July '22 Cantor Fitzgerald
Neutral07 June '22 HC Wainwright & Co.
Neutral06 May '22 Cantor Fitzgerald
Neutral11 Mar '22 HC Wainwright & Co.
Buy12 Nov '21 HC Wainwright & Co.
Buy07 Aug '20 Jefferies
Underperform19 May '20 JP Morgan
Neutral07 May '20 H.C. Wainwright
Buy16 Apr '20 Stifel
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
TherapeuticsMD doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TXMD
benzinga.com26 August 2024
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy
TXMD
Zacks Investment Research14 April 2023
TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FAQ
- What is the primary business of TherapeuticsMD?
- What is the ticker symbol for TherapeuticsMD?
- Does TherapeuticsMD pay dividends?
- What sector is TherapeuticsMD in?
- What industry is TherapeuticsMD in?
- What country is TherapeuticsMD based in?
- When did TherapeuticsMD go public?
- Is TherapeuticsMD in the S&P 500?
- Is TherapeuticsMD in the NASDAQ 100?
- Is TherapeuticsMD in the Dow Jones?
- When was TherapeuticsMD's last earnings report?
- When does TherapeuticsMD report earnings?
- Should I buy TherapeuticsMD stock now?
What is the primary business of TherapeuticsMD?
TherapeuticsMD (TXMD) is a healthcare company focused on developing and providing innovative products for women's health. They create prescription medications and over-the-counter solutions to address issues like menopause, contraception, and other female health needs, aiming to improve the quality of life for women.
What is the ticker symbol for TherapeuticsMD?
The ticker symbol for TherapeuticsMD is NASDAQ:TXMD
Does TherapeuticsMD pay dividends?
No, TherapeuticsMD does not pay dividends
What sector is TherapeuticsMD in?
TherapeuticsMD is in the Healthcare sector
What industry is TherapeuticsMD in?
TherapeuticsMD is in the Drug Manufacturers - Specialty & Generic industry
What country is TherapeuticsMD based in?
TherapeuticsMD is headquartered in United States
When did TherapeuticsMD go public?
TherapeuticsMD's initial public offering (IPO) was on 09 May 2007
Is TherapeuticsMD in the S&P 500?
No, TherapeuticsMD is not included in the S&P 500 index
Is TherapeuticsMD in the NASDAQ 100?
No, TherapeuticsMD is not included in the NASDAQ 100 index
Is TherapeuticsMD in the Dow Jones?
No, TherapeuticsMD is not included in the Dow Jones index
When was TherapeuticsMD's last earnings report?
TherapeuticsMD's most recent earnings report was on 12 November 2024
When does TherapeuticsMD report earnings?
The next expected earnings date for TherapeuticsMD is 5 March 2025
Should I buy TherapeuticsMD stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions